Fig. 5.
Effect of blocking RA synthesis by DEAB in efhc2-Mo morphants during pronephros segmentation. a Wild-type embryos or efhc2-Mo morphants were treated with DEAB (1 × 10−5 M). Morphological changes caused by DEAB treatment in wild-type and efhc2 morphants. efhc2-Mo morphants treated with DEAB show expansion of expression domain of DE marker slc12a1 and slight reduction of DL and CS markers slc12a3 and stc1 as compared with wild-type embryos treated with DEAB. b Summary of the effects of DEAB on WT and efhc2-Mo morphants at 48 hpf